REVIEWSelf-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
Under a Creative Commons license
open access
Graphical abstract
The advancements of paclitaxel (PTX) nanoformulations based on self-assembly of pure drugs, homodimeric prodrug, heterodimeric prodrug, or poly-prodrug for mono-chemotherapy, combinational therapy and theranostics are presented.
Key words
Paclitaxel
Self-assembly
Homodimeric prodrug
Heterodimeric prodrug
Poly-prodrug
Chemotherapy
Combinational therapy
Theranostics
Cited by (0)
Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.
© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.